Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,700 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
International Journal of Stroke, 2024Are central and systemic inflammation associated with fatigue in cerebral small vessel disease?
Jolly A., Brown R., Tozer D. et al.
Olink Target 96
Frontiers in Aging Neuroscience, 2024Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and amyotrophic lateral sclerosis
Xiao C., Gu X., Feng Y. et al.
Frontiers in Immunology, 2024Genetic insight into putative causes of xanthelasma palpebrarum: a Mendelian randomization study
Hu W., Liu Y., Lian C. et al.
Journal of Translational Medicine, 2024Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis
Kong T., Qu Y., Zhao T. et al.
European Journal of Heart Failure, 2024Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort
Kobayashi M., Ferreira J., Duarte K. et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology
Jauhiainen S., Onyeogaziri F., Lazzaroni F. et al.
Brain, 2024Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia
Reus L., Jansen I., Tijms B. et al.
SLEEP, 2024Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer’s disease
Baril A., Picard C., Labonté A. et al.
JOR SPINE, 2024No evidence of association between either Modic change or disc degeneration and five circulating inflammatory proteins
Compte R., Freidin M., Granville Smith I. et al.
Anaerobe, 2024Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infection
Ramakrishnan G., Young M., Nayak U. et al.
Olink Target 48
Genome Medicine, 2024Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease
Møller P., Rohde P., Dahl J. et al.
Canadian Journal of Gastroenterology and Hepatology, 2024The Role of Inflammatory Biomarkers in Mediating the Effect of Inflammatory Bowel Disease on nonmalignant Digestive System Diseases: A Multivariable Mendelian Randomized Study
Zhou S., Sun Q., Gao N. et al.
Nature Metabolism, 2024Lac-Phe mediates the effects of metformin on food intake and body weight
Xiao S., Li V., Lyu X. et al.
Olink Explore 3072/384
Journal of Cellular and Molecular Medicine, 2024Microglia orchestrate synaptic and neuronal stripping: Implication in neuropsychiatric lupus
Zhou Y., Chen L., Zheng X. et al.
Advanced Science, 2024In Vitro Transcribed mRNA Immunogenicity Induces Chemokine‐Mediated Lymphocyte Recruitment and Can Be Gradually Tailored by Uridine Modification
Drzeniek N., Kahwaji N., Picht S. et al.
Journal of Clinical Immunology, 2024Inflammatory Proteomic Analysis of 22q11.2 Deletion Syndrome
Frusone V., Maurer K., Emanuel B. et al.
Hypertension, 2024Identification of Circulating Plasma Proteins as a Mediator of Hypertension-Driven Cardiac Remodeling: A Mediation Mendelian Randomization Study
Hu Y., Lin L., Zhang L. et al.
Cell Reports Methods, 2024A multi-omics systems vaccinology resource to develop and test computational models of immunity
Shinde P., Soldevila F., Reyna J. et al.
eBioMedicine, 2024Implantation of a double allogeneic human engineered tissue graft on damaged heart: insights from the PERISCOPE phase I clinical trial
Bayes-Genis A., Gastelurrutia P., Monguió-Tortajada M. et al.
Vaccines, 2024Cell-Mediated Proteomics, and Serological and Mucosal Humoral Immune Responses after Seasonal Influenza Immunization: Characterization of Serological Responders and Non-Responders
Carlsson H., Brudin L., Serrander L. et al.
2798 publications
Items per page
861-880 of 2798 publications